Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps
- PMID: 31000678
- DOI: 10.1183/13993003.00610-2019
Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps
Conflict of interest statement
Conflict of interest: I. Blanco has nothing to disclose. Conflict of interest: I. Diego has nothing to disclose. Conflict of interest: P. Bueno has nothing to disclose. Conflict of interest: F. Casas-Maldonado has nothing to disclose. Conflict of interest: M. Miravitlles reports speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, Zambon, CSL Behring, Grifols and Novartis, consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratorios Esteve, Ferrer, Mereo Biopharma, Verona Pharma, TEVA, pH Pharma, Novartis and Grifols, and research grants from GlaxoSmithKline and Grifols, outside the submitted work.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical